Orlistat PD Endpoint Determination during BE study [Design Issues]

posted by patilatu – 2015-03-09 08:36 (4130 d 23:38 ago) – Posting: # 14553
Views: 6,739

Dear All,

❝ Done one study on orlistat.


❝ And believe me, it is going to be a tough one!! (main problem was keeping volunteers in the facility for ~45-60 day apart from the fecal collection method).


Yes, I agree. It is logistically very tough. The volunteer availability is a big issue for such a long period.

regards
Patilatu

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
300 visitors (0 registered, 300 guests [including 34 identified bots]).
Forum time: 09:15 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5